AnalystsThomas Smith
Thomas Smith's Stock Forecasts

Analyst Ranking
Top 7%
#343 out of 4867 analysts
Average Return
+28.53%
Win Rate
35%24 out of 69
Risk vs Reward
Poor
Good

Thomas Smith's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Viking Therapeutics IncVKTX
+710.33%$2.42$19.61
2022-04-27 -
2023-04-27
Buy
Moonlake ImmunotherapeuticsMLTX
+499.03%$9.27$55.53
2022-08-24 -
2023-08-24
Buy
89bio IncETNB
+488.18%$3.30$19.41
2022-07-10 -
2023-07-10
Buy
Prometheus Biosciences IncRXDX
+313.14%$48.39$199.92
2022-08-11 -
2023-06-15
Buy
89bio IncETNB
+293.00%$4.14$16.27
2022-03-24 -
2023-03-24
Buy

Thomas Smith Analyst Color

Get additional color on Thomas Smith's coverage of popular stocks

Thomas Smith's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Equillium IncEQ
4Hold$1.00+118.34%Downgrades
a month ago
Q32 Bio IncQTTB
2Hold$9.00+434.12%Downgrades
5 months ago
Aclaris Therapeutics IncACRS
3Buy$7.00+414.71%Upgrades
5 months ago
Alumis IncALMS
1Buy$29.00+603.88%Initiates Coverage On
9 months ago
Cartesian Therapeutics IncRNAC
1Buy$39.00N/AInitiates Coverage On
a year ago
Alpine Immune Sciences IncALPN
2Hold$65.00N/ADowngrades
a year ago
Sagimet Biosciences IncSGMT
1Buy$26.00N/AInitiates Coverage On
a year ago
Rapt Therapeutics IncRAPT
2Hold$10.00N/ADowngrades
a year ago
Cymabay Therapeutics IncCBAY
2Hold$32.50N/ADowngrades
a year ago
Abivax SaABVX
1Buy$20.00N/AInitiates Coverage On
a year ago
Vectivbio Holding AgVECT
3Hold$17.00N/ADowngrades
2 years ago
Morphic Holding IncMORF
1Buy$56.00N/AMaintains
2 years ago
Argenx SeARGX
3Buy$435.00N/AMaintains
2 years ago
Intercept Pharmaceuticals IncICPT
4Hold$18.00N/AMaintains
2 years ago
Disc Medicine IncIRON
1Buy$36.00N/AInitiates Coverage On
2 years ago
Connect Biopharma Holdings LtdCNTB
4Buy$7.00N/AMaintains
2 years ago
Immunovant IncIMVT
3Buy$21.00N/AMaintains
2 years ago
Viridian Therapeutics IncVRDN
2Buy$45.00N/AMaintains
2 years ago
Trevi Therapeutics IncTRVI
1Buy$6.00N/AInitiates Coverage On
2 years ago
Provention Bio IncPRVB
2Buy$19.00N/AMaintains
2 years ago
Landos Biopharma IncLABP
4Hold$20.00N/AMaintains
2 years ago
Mannkind CorpMNKD
2Buy$6.00N/AMaintains
2 years ago
Immunic IncIMUX
3Hold$5.00N/ADowngrades
3 years ago
Dice Therapeutics IncDICE
1Buy$77.00N/AMaintains
3 years ago
Moonlake ImmunotherapeuticsMLTX
1Buy$17.00N/AInitiates Coverage On
3 years ago
Prometheus Biosciences IncRXDX
5Buy$60.00N/AMaintains
3 years ago
Celldex Therapeutics IncCLDX
2Buy$64.00N/AMaintains
3 years ago
Puretech Health PLCPRTC
5Buy$70.00N/AMaintains
3 years ago
Axcella Health IncAXLA
5Buy$150.00N/AMaintains
3 years ago
89bio IncETNB
3Buy$29.00N/AMaintains
3 years ago
Eledon Pharmaceuticals IncELDN
3Buy$26.00N/AMaintains
3 years ago
Allakos IncALLK
3Hold$12.00N/AMaintains
3 years ago
Viking Therapeutics IncVKTX
1Buy$12.00N/AMaintains
3 years ago
Genfit SaGNFT
2Buy$10.00N/AMaintains
3 years ago
Galecto IncGLTO
2Buy$400.00N/AMaintains
4 years ago
Keros Therapeutics IncKROS
1Buy$42.00N/AInitiates Coverage On
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.